|
End-of-day quote
Shenzhen S.E.
2026-10-21
|
5-day change | 1st Jan Change | ||
| 5.640 CNY | +0.53% |
|
-0.35% | +16.05% |
| Market Cap | 1.79B 269M 239M 222M 201M 378M 25.35B 382M 2.66B 1.04B 13.32B 1.01B 987M 42.46B | P/E 2024 |
-16.5x | P/E 2025 | -27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.87B 280M 250M 231M 209M 394M 26.46B 399M 2.77B 1.09B 13.91B 1.05B 1.03B 44.33B | EV / Sales 2024 |
2.7x | EV / Sales 2025 | 3.16x |
| Free-Float |
52.28% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.53% | ||
| 1 week | -0.35% | ||
| Current month | -8.89% | ||
| 1 month | -6.78% | ||
| 3 months | +20.77% | ||
| 6 months | +12.80% | ||
| Current year | +16.05% |
| 1 week | 5.48 |  | 5.73 |
| 1 month | 5.48 | | 6.28 |
| Current year | 4.32 | | 6.28 |
| 1 year | 4.32 | | 6.28 |
| 3 years | 3.17 | | 6.28 |
| 5 years | 3.17 | | 6.28 |
| 10 years | 3.17 | | 35.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 33 | 2018-12-05 |
Kai Sheng Wang
DFI | Director of Finance/CFO | 52 | 2013-12-22 |
Zonghua Tan
PRN | Corporate Officer/Principal | 54 | 2020-12-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Ding Qing Li
BRD | Director/Board Member | 63 | 2020-12-10 |
Shuang Liu
CHM | Chairman | 33 | 2018-12-05 |
Zonghua Tan
BRD | Director/Board Member | 54 | 2020-12-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/25/23 | Sell | Chief Financial Officer | 43,100 | 0.0205% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | -0.35% | +12.35% | +13.25% | 269M | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| -0.60% | +2.32% | +38.50% | +63.54% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.45% | +1.06% | +21.34% | +50.58% | 292B | |
| -0.16% | -1.04% | +0.21% | +24.42% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | -0.10% | +2.98% | +32.91% | +63.30% | 398.83B | |
| Weighted average by Cap. | +0.22% | +3.73% | +40.67% | +79.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 570M 85.32M 76.03M 70.39M 63.7M 120M 8.05B 121M 844M 331M 4.23B 320M 313M 13.49B | 514M 76.99M 68.61M 63.52M 57.48M 108M 7.27B 110M 762M 299M 3.82B 289M 283M 12.17B |
| Net income | -87.4M -13.09M -11.66M -10.8M -9.77M -18.41M -1.24B -18.63M -129M -50.81M -649M -49.11M -48.08M -2.07B | -55.42M -8.3M -7.4M -6.85M -6.2M -11.68M -783M -11.81M -82.11M -32.22M -412M -31.14M -30.49M -1.31B |
| Net Debt | 97.19M 14.56M 12.97M 12.01M 10.87M 20.47M 1.37B 20.72M 144M 56.49M 722M 54.6M 53.47M 2.3B | 78.93M 11.82M 10.53M 9.75M 8.83M 16.63M 1.12B 16.82M 117M 45.88M 586M 44.34M 43.42M 1.87B |
Employees
1,273
Sector
Pharmaceuticals
Calendar
Oct. 28
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | CN¥5.640 | +0.53% | 2,439,200 |
| 26-10-20 | CN¥5.610 | +1.08% | 2,604,500 |
| 26-10-19 | CN¥5.550 | -0.72% | 4,309,050 |
| 26-10-16 | CN¥5.590 | 0.00% | 2,799,500 |
| 26-10-15 | CN¥5.590 | -1.24% | 3,230,100 |
- Stock Market
- Stocks
- 002872 Stock
Select your edition
All financial news and data tailored to specific country editions
